Pig Kidney Transplant: 271-Day Medical Breakthrough
A pig kidney transplant has reached a major new milestone after a US patient lived for 271 days without dialysis using a genetically modified pig kidney before receiving a human donor kidney. The case is being described as a significant step forward for xenotransplantation and could eventually help address the shortage of human organs available for transplantation.
Tim Andrews, a patient from New Hampshire, received the genetically modified kidney in January 2025 at Massachusetts General Hospital in Boston. At the time, he had end-stage kidney disease and had spent more than two years undergoing dialysis.
The experimental transplant gave Andrews a period of independence from dialysis while he waited for a human donor organ. Although the pig kidney eventually had to be removed, doctors were subsequently able to perform a successful human kidney transplant.
The case is particularly important because it demonstrates a potential new role for animal organs: serving as a temporary bridge for patients who might otherwise spend months or years waiting for a suitable human donor.
Pig kidney transplant sets a new milestone
Andrews’ experience represents the longest reported period that a genetically modified pig kidney has supported a living human without dialysis.
According to the medical team, the kidney functioned for 271 days. After that period, problems developed in the organ’s blood vessels, causing its performance to deteriorate.
The kidney was eventually removed, and Andrews returned to dialysis while remaining in need of a human organ.
Several months later, however, he received a kidney from a deceased human donor. The human transplant functioned successfully during follow-up.
Researchers say the sequence is important because it demonstrates that a patient can potentially move from an animal kidney to a human kidney without the earlier xenotransplant preventing the later procedure.
The findings were reported by the medical team involved in the case and published in The Lancet. TThe Guardian+1
Why the pig kidney transplant matters
Kidney failure is different from failure of some other organs because dialysis can keep a patient alive for an extended period. However, dialysis is demanding and can have a major impact on daily life.
Patients must regularly undergo treatment to remove waste and excess fluid from their blood because their kidneys can no longer perform that work adequately.
A successful kidney transplant can offer greater independence and, for suitable patients, better long-term outcomes than remaining on dialysis.
The problem is that there are not enough human donor kidneys for everyone who needs one.
That shortage has encouraged researchers to investigate whether organs from animals could eventually be modified so that they can safely function inside humans.
Pigs are considered particularly promising because their organs are broadly similar in size and physiology to human organs. However, the human immune system recognizes a pig organ as foreign and can attack it aggressively.
That immune barrier has been one of the biggest challenges facing xenotransplantation.
How the genetically modified kidney was created
The kidney used for Andrews came from a genetically modified pig.
Researchers used gene-editing technology to make the pig organ more compatible with a human recipient. The kidney donor, a Yucatan miniature pig, underwent extensive genetic modification before the organ was transplanted.
The organ contained 69 genomic edits, according to Mass General Brigham.
Some modifications were designed to reduce the risk of immediate immune rejection. Other changes were intended to improve compatibility between the pig organ and human biological systems.
Researchers also sought to reduce the risk of pig-derived viruses being transmitted to the human recipient. MMass General Brigham News+1
The approach illustrates why modern xenotransplantation is very different from earlier attempts to transplant animal organs into humans.
Instead of simply taking an organ from an animal and placing it inside a person, scientists are now attempting to redesign the biological characteristics of the donor animal.
Gene-editing technologies such as CRISPR have made increasingly sophisticated modifications possible.
Pig kidney transplant initially worked well
The early results in Andrews’ case were encouraging.
After the operation, the transplanted kidney began producing urine and provided enough kidney function for Andrews to stop dialysis.
That change had a major effect on his daily life.
After spending years dealing with dialysis and declining health, Andrews was able to return to activities that had previously become difficult.
His experience highlights one of the central arguments for using a pig kidney as a bridge therapy.
The goal does not necessarily have to be keeping the animal organ functioning permanently.
Instead, an experimental pig kidney could potentially keep a patient alive and off dialysis until a suitable human kidney becomes available.
That distinction could prove important for future clinical trials.
Why did the pig kidney eventually fail?
The kidney did not provide permanent function.
After approximately six months, doctors observed damage involving blood vessels inside the transplanted organ. The problem progressed, eventually causing the kidney to lose its ability to function adequately.
The medical team had to remove the organ after 271 days.
Researchers believe the failure involved complex immune and vascular processes rather than a simple rejection event.
The case therefore also provides valuable information about what scientists need to solve before pig kidneys can become a routine treatment.
Understanding how blood vessels, immune cells and genetically modified animal tissue interact over long periods could help researchers improve future organs.
The experience also demonstrates why xenotransplantation remains experimental.
The human kidney transplant was another milestone
The most striking part of Andrews’ story came after the pig kidney was removed.
Rather than remaining dependent on dialysis indefinitely, Andrews later received a human kidney from a deceased donor.
Doctors reported that the human kidney worked successfully.
Importantly, researchers found no evidence that the previous pig kidney transplant had created new antibodies against human tissue that would prevent the subsequent human transplant.
They also reported that no pig viruses or other pig pathogens were detected.
That finding could be significant for the future of bridge xenotransplantation.
If a genetically modified pig kidney can temporarily support a patient without compromising their ability to receive a human kidney later, the strategy could become another tool for managing long transplant waiting lists. TThe Guardian+1
What is xenotransplantation?
Xenotransplantation is the transplantation of cells, tissues or organs between different species.
In this case, researchers are attempting to use genetically modified pig organs in humans.
The concept has been studied for decades, but previous attempts faced major obstacles.
The immune system can recognize animal tissue as foreign. In severe cases, rejection can occur rapidly.
There are also concerns about infections, blood-clotting problems and other biological differences between humans and animals.
Modern genetic engineering is designed to address several of these problems at once.
Scientists can remove or alter pig genes associated with immune rejection and introduce genetic changes intended to make the organ more compatible with the human body.
However, successful short-term transplantation does not automatically mean that the approach is ready for widespread medical use.
Organ shortages remain the biggest challenge
The potential importance of pig kidney transplantation is closely linked to the global shortage of human donor organs.
Thousands of people wait for kidney transplants, while many others remain on dialysis because they cannot receive an organ in time.
For some patients, the wait can be especially difficult because their age, medical condition, blood type or other factors can reduce their chances of receiving a suitable kidney.
Mass General Brigham has described xenotransplantation as a possible response to this problem.
Its researchers envision a future in which genetically modified animal organs could initially be used to help patients survive while they wait for human organs. In the longer term, researchers hope some animal organs could potentially become permanent replacement organs. MMass General Brigham News+1
That second possibility remains much more challenging.
A temporary bridge only needs to provide useful function for a limited period. A permanent transplant would need to remain healthy and functional for many years.
The 271-day result does not prove pig kidneys are ready
Despite the excitement surrounding Andrews’ case, researchers have emphasized that it is still an early-stage development.
The experience involved a single patient and did not include a conventional comparison group.
That means doctors cannot yet determine how consistently genetically modified pig kidneys will work in larger populations.
Future clinical trials will be necessary to establish safety, effectiveness and long-term outcomes.
Researchers will also need to determine which genetic modifications work best, what immunosuppressive treatments are required and how to prevent blood-vessel damage.
These questions are particularly important because patients receiving experimental organs may already have serious health problems.
The medical team must therefore balance the potential benefits of xenotransplantation against significant medical risks.
A new direction for kidney transplantation
The significance of Andrews’ case extends beyond the 271-day record.
The more important achievement may be the successful transition from a genetically modified pig kidney to a human kidney.
For patients with kidney failure, that could eventually create a new treatment pathway.
Instead of remaining on dialysis while waiting for a donor, a patient could potentially receive a pig kidney first. The animal organ could provide kidney function during the waiting period.
When a suitable human organ becomes available, doctors could then replace the pig kidney with a human one.
Such a system would not eliminate the need for human donors.
Instead, it could provide an additional option for patients who face long or uncertain waits.
What happens next for pig kidney research?
Researchers are expected to continue studying genetically modified pig organs through carefully controlled clinical trials.
The next generation of pig kidneys will likely focus on the problems revealed by earlier procedures.
Scientists need to better control immune responses, protect blood vessels and reduce the risk of infection.
They also need to understand how different genetic modifications interact with the human immune system over longer periods.
Another important issue is manufacturing.
If xenotransplantation eventually becomes a standard treatment, hospitals would need a reliable supply of organs from specially managed donor pigs.
That would require strict controls over animal breeding, genetic modification, infectious disease monitoring and organ preparation.
The regulatory framework would also need to evolve alongside the science.
A potential lifeline for patients on dialysis
For Andrews, the medical breakthrough was personal.
The pig kidney gave him months without dialysis at a time when his health had already been severely affected by kidney disease.
For researchers, however, the case represents something larger.
It provides evidence that a genetically modified animal organ can support a human long enough to potentially bridge the gap to a conventional transplant.
Mass General Brigham researchers have described patients participating in these early studies as pioneers because their experiences provide information that cannot be obtained through laboratory research alone. MMass General Brigham News
The road to routine xenotransplantation remains uncertain.
Still, the 271-day result represents a meaningful advance.
If future trials can make pig kidneys safer, more durable and more predictable, genetically modified animal organs could eventually become an important part of the response to the world’s kidney transplant shortage.
For now, Andrews’ journey offers a glimpse of what that future might look like: an animal organ keeping a patient alive and independent while they wait for the human kidney they ultimately need.
That is why the case is being viewed not simply as a record, but as a potentially important new chapter in transplantation medicine.
Image ALT Text
Genetically modified pig kidney transplant used to help kidney failure patient before human kidney transplant
Suggested Image
Use an editorial or hospital-provided image showing Tim Andrews and the medical team at Massachusetts General Hospital, or a clearly labeled illustrative image of a genetically modified pig kidney transplant. Avoid using an unrelated stock image presented as the actual transplant.
External Sources
- BBC News source article
- Mass General Brigham — genetically edited pig kidney transplant research
- eGenesis — Tim Andrews patient story
Internal links: Not included because no target website/domain was provided. You can add relevant links from your own site to articles about kidney disease, dialysis, organ transplantation, medical breakthroughs, CRISPR, or biotechnology.
SEO note: The title is 57 characters, the slug is well below 75 characters, and the meta description is under 160 characters. The keyword has been deliberately used naturally rather than forcing an exact 1% density, since excessive repetition can hurt readability and SEO
